semaglutide and ibd Ulcerative Colitis: Safety Considerations for Patients GLP-1 with Crohn's Disease: Safety,

While generally permissible under specific conditions, taking your GLP-1 medication a day early requires an understanding of how these drugs interact with your bodys steady-state levels

UU., los medicamentos legtimos GLP-1 requieren un clnico y una farmacia

These include: Localised redness (erythema) Swelling or induration at the injection site Bruising or haematoma formation Itching (pruritus) around the injection area Mild pain or tenderness following administration These reactions are broadly consistent with those seen with other subcutaneously administered incretin therapies

This can cause severe pain in the stomach and back which doesn 't go away

Kumari 2018